drugset / Trial / NCT02595723
Phenytoin for Memory Impairment Secondary to Megestrol
Phase 4
Completed
21 enrolled
University of Texas Southwestern Medical Center
The Rogosin Institute · collab
RandomizedCrossoverQuadruple-blindOther
Summary
This study is designed to test if megestrol acetate induces changes in declarative memory in healthy controls and if pre-administration of phenytoin can ameliorate any induced cognitive impairments.
Timeline
- Start
- 2015-07
- Primary completion
- 2016-11
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Megestrol Acetate | Other / unclassified | 800 mg | — |
| Subject | Phenytoin | Unknown | 200 mg | Oral |